Table III.

Genes down-regulated by BRs in WT

Gene NameAccession No.Function or CommentAffymetrix No.det2WT
AmplifiedNo-Amp.AmplifiedNo-Amp.
FC ± seFC ± seFC ±seFC ± se
CYP79B2 AF069495 Cytochrome P45020479_i_at−0.4 ± 0.70−0.4 ± 0.68−1.6 ± 0.35−2.2 ± 0.05
CYP81D8 AL035601/F6G17.20Cytochrome P45014032_at−2.0 ± 0.50−0.7 ± 1.07−3.7 ± 0.20−1.9 ± 0.15
4HPPD AF047834 4-Hydroxyphenylpyruvate dioxygenase15669_s_at−2.4 ± 0.30−2.3 ± 0.30−6.9 ± 1.60−3.0 ± 0.30
CHI M86358 Chalcone isomerase20413_at−1.4 ± 0.15−1.3 ± 0.12−2.2 ± 0.05−2.3 ± 0.45
BRI1 AF017056 BRI120209_at−1.8 ± 0.06−1.9 ± 0.13−2.0 ± 0.05−2.0 ± 0.20
Eli3-1 X67816 Cinnamyl-alcohol dehydrogenase13242_at−1.9 ± 0.25−1.9 ± 0.15−1.7 ± 0.00−2.1 ± 0.05
BRD13 AL021713/T9A21.60Putative protein13514_s_at−1.9 ± 0.74−1.8 ± 0.03−4.0 ± 0.50−2.0 ± 0.35
BRD14 AC006085/F11M15.3Putative Ser/Thr protein kinase16878_at−3.3 ± 0.56−1.8 ± 0.74−4.0 ± 0.10−1.8 ± 0.00
BRD15 AC012562/F17O14.23Osmotic stress-inducible kinase like-protein13246_at−1.8 ± 0.39−0.6 ± 0.83−3.8 ± 1.10−1.9 ± 0.70
BRD16 AL049480/F14M19.60Putative pathogenesis-related protein18755_at−2.1 ± 0.38−2.0 ± 0.68−2.6 ± 0.50−2.0 ± 0.25
BRD17 AL033545/F7K2.50Extensin-like protein12115_at−2.2 ± 0.19−1.8 ± 0.10−2.4 ± 0.25−2.3 ± 0.05
BRD18 AC005662/F13H10.7Putative embryo-abundant protein14083_at−2.0 ± 0.15−1.8 ± 0.27−2.4 ± 0.15−2.2 ± 0.15
BRD19 Y12776 Late embryogenesis-abundant protein like-protein18594_at−1.5 ± 0.09−1.6 ± 0.09−2.1 ± 0.05−2.0 ± 0.00
BRD20 AL021811/F10M6.70Putative protein14574_at−2.8 ± 0.38−2.4 ± 0.52−1.8 ± 0.15−2.2 ± 0.15
BRD21 AC007661/T8P21.9Putative protein15487_at−1.6 ± 0.12−1.6 ± 0.29−1.8 ± 0.55−2.1 ± 0.05

When genes have names on publications or on database, we adopted their names. Otherwise, we designed genes from BRD13 to BRD21. Amplified and No-Amp., before and after signal amplification with antibody, respectively.